A Study in Adults With Geographic Atrophy
Public ClinicalTrials.gov record NCT07606365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicentre, Randomised, Double-masked, Placebo-controlled, Parallel-group, Dose-range Finding Study, to Assess the Efficacy and Safety of Oral STL303 in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.
Study identification
- NCT ID
- NCT07606365
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jul 31, 2029
- Last update posted
- May 27, 2026
2026 – 2029
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Retina Consultants | Bakersfield | California | 93309 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Kaiser Permanente - Oakland | Oakland | California | 94612 | — |
| Retina Specialists of Colorado | Aurora | Colorado | 80012 | — |
| Retina Group of New England, PC | Waterford | Connecticut | 06385 | — |
| Retina Vitreous Associates of Florida | St. Petersburg | Florida | 33711 | — |
| Florida Retina Institute | Wildwood | Florida | 34785 | — |
| University Retina and Macula Associates, P.C. | Lemont | Illinois | 60439 | — |
| Associated Vitreoretinal and Uveitis Consultants | Carmel | Indiana | 46032 | — |
| Cumberland Valley Retina Consultants,P.C. | Hagerstown | Maryland | 21740 | — |
| Mid Atlantic Retina Specialists | Hagerstown | Maryland | 21740 | — |
| Ophthalmic Consultants of Boston | Waltham | Massachusetts | 02451 | — |
| Long Island and Queens Vitreoretinal Consultants of NY, P.C. | Hauppauge | New York | 11788 | — |
| Erie Retina Research | Erie | Pennsylvania | 16507 | — |
| Tennessee Retina, PC | Nashville | Tennessee | 37203 | — |
| Retina Consultants of Texas | Bellaire | Texas | 77401 | — |
| Star Vision Research | Burleson | Texas | 76028 | — |
| Retina Consultants of Texas | Schertz | Texas | 78154 | — |
| Northeast Wisconsin Retina Associates | Appleton | Wisconsin | 54914 | — |
| Eye Clinic of Wisconsin | Wausau | Wisconsin | 54403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07606365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07606365 live on ClinicalTrials.gov.